Shareholding16 Oct 2026, 10:14 am
Kotak Mahindra MF Acquires Over 5% Stake in Molbio Diagnostics
AI Summary
Kotak Mahindra Mutual Fund (KMMF) has disclosed its acquisition of over 5.00% of the total equity share capital of Molbio Diagnostics Limited. The acquisition, made through various KMMF schemes via open market transactions, brings KMMF's total holding to 5.4834%. The disclosure was made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011. The total number of equity shares held by KMMF after the acquisition is 6,319,083 out of a total of 115,239,996 equity shares.
Key Highlights
- Kotak Mahindra Mutual Fund acquired over 5% stake in Molbio Diagnostics.
- KMMF's total holding in Molbio Diagnostics now stands at 5.4834%.
- The acquisition was made through open market transactions.
- Disclosure filed under SEBI SAST Regulations, 2011.
- Total shares held by KMMF post-acquisition: 6,319,083.
Price Impact
More from MOLBIO